General Information of the Protein
Protein ID |
PT01670
|
||||
---|---|---|---|---|---|
Protein Name |
Calcitonin gene-related peptide type 1 receptor
|
||||
Secondarily Protein Name |
Calcitonin receptor-like receptor
|
||||
Gene Name |
CALCRL
|
||||
Secondarily Gene Name |
CGRPR
|
||||
Sequence |
MEKKCTLYFLVLLPFFMILVTAELEESPEDSIQLGVTRNKIMTAQYECYQKIMQDPIQQAEGVYCNRTWDGWLCWNDVAAGTESMQLCPDYFQDFDPSEKVTKICDQDGNWFRHPASNRTWTNYTQCNVNTHEKVKTALNLFYLTIIGHGLSIASLLISLGIFFYFKSLSCQRITLHKNLFFSFVCNSVVTIIHLTAVANNQALVATNPVSCKVSQFIHLYLMGCNYFWMLCEGIYLHTLIVVAVFAEKQHLMWYYFLGWGFPLIPACIHAIARSLYYNDNCWISSDTHLLYIIHGPICAALLVNLFFLLNIVRVLITKLKVTHQAESNLYMKAVRATLILVPLLGIEFVLIPWRPEGKIAEEVYDYIMHILMHFQGLLVSTIFCFFNGEVQAILRRNWNQYKIQFGNSFSNSEALRSASYTVSTISDGPGYSHDCPSEHLNGKSIHDIENVLLKPENLYN
Show/Hide
|
||||
Organism |
Homo sapiens, Human
|
||||
Protein Classification |
Membrane receptor
>
Family B G protein-coupled receptor
>
Peptide receptor (family B GPCR)
>
Calcitonin-like receptor
>
Calcitonin gene-related peptide receptor
|
||||
Function |
Receptor for calcitonin-gene-related peptide (CGRP) together with RAMP1 and receptor for adrenomedullin together with RAMP3 (By similarity). Receptor for adrenomedullin together with RAMP2 (PubMed:22102369, PubMed:30115739). The activity of this receptor is mediated by G proteins which activate adenylyl cyclase (PubMed:22102369, PubMed:30115739).
Show/Hide
|
||||
Uniprot ID |
Show/Hide
|
||||
Ensembl ID | |||||
HGNC ID | |||||
Subcellular Location |
Cell membrane
|
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Cell Line ID: CL000006 , HEK293
Cell Line ID: CL000748 , NAL1A clone C4E10
Cell Line ID: CL000074 , SK-N-MC
Biochemical Assays
Clinical Information about the Protein
Target 1 ( Calcitonin gene-related peptide receptor (CGRPR) )
Target Type | Successful Target | ||||
---|---|---|---|---|---|
Disease | 2 Target-related Diseases | 2 | |||
1 | Migraine [ICD-11: 8A80] | ||||
2 | Cluster headache [ICD-11: 8A81.0] | ||||
Approved Drug(s) | 4 Approved Drugs | 4 | |||
1 | Rimegepant | Approved | |||
2 | Ubrogepant | Approved | |||
3 | Atogepant | Approved | |||
4 | Zavegepant | Approved | |||
Clinical Trial Drug(s) | 3 Clinical Trial Drugs | 3 | |||
1 | MK-3207 | Phase 2 | |||
2 | Olcegepant | Phase 2 | |||
3 | Telcagepant | Phase 2 | |||
Investigative Drug(s) | 1 Investigative Drug | 1 | |||
1 | BMS-694153 | Investigative |
Target 2 ( HUMAN calcitonin gene-related peptide type 1 receptor (CALCRL) )
Target Type | Unknown Type Target |
---|